Physiologic colonic uptake of 18F-FDG on PET/CT predicts immunotherapy response and gut microbiome diversity in patients with advanced non-small cell lung cancer (NSCLC).

Lena Cvetkovic,Claudine Régis,Valerio Iebba,Lisa Derosa,Antoine Leblond,Julie Malo,Meriem Messaoudene,Wiam Belkaid,Arielle Elkrief,Bertrand Routy,Daniel Juneau

Physiologic colonic uptake of 18F-FDG on PET/CT predicts immunotherapy response and gut microbiome diversity in patients with advanced non-small cell lung cancer (NSCLC).

2020

Lena Cvetkovic
Claudine Régis
Valerio Iebba
Lisa Derosa
Antoine Leblond
Julie Malo
Meriem Messaoudene
Wiam Belkaid
Arielle Elkrief
Bertrand Routy
Daniel Juneau

9600Background: Immune checkpoint inhibitors (ICI) represent the backbone treatment of advanced non-small cell lung cancer (aNSCLC) patients. Emerging evidence suggests increased gut microbiome (GM...

Keywords:

PET-CT
Oncology
in patient
Immunotherapy
gut microbiome
Pathology
non-small cell lung cancer (NSCLC)
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations